Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
Lepu Biopharma Co., Ltd. 2157.HK
$5.55
+$0.31 (5.51%)
На 18:05, 12 мая 2023
Ключевые показатели
-
Marketcap
8463143546.00000000
-
week52high
31.80
-
week52low
4.92
-
Revenue
-
P/E TTM
0
-
Beta
0.00000000
-
EPS
-0.59000000
-
Last Dividend
0.00000000
-
Next Earnings Date
26 апр 2023 г. в 16:00
Описание компании
Lepu Biopharma Co., Ltd., a biopharmaceutical company, focuses on developing oncology therapeutics with a pipeline designed with a range of oncology products in China. The company develops oncology drug candidates, including antibody-drug conjugates (ADC), oncolytic virus drugs, and immunotherapies. It develops immuno-oncology products, such as HX008 Anti-PD-1 mAb and LP002 Anti-PD-L1 mAb; ADC products, including MRG003 EGFR-targeted ADC, MRG002 HER2-targeted ADC, MRG001 CD20-targeted ADC, MRG004A TF-targeted ADC, and CMG901 CLDNI8.2-targeted ADC; CG0070 oncolytic virus; and other drug candidates, such as HX008+OH2, LP002+OH2, and HX008+LP002. The company was incorporated in 2018 and is headquartered in Shanghai, China.
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Свежие комментарии
Свежие комментарии